This study compares the characteristics and outcomes among liver transplant recipients with radiographically apparent hepatocellular carcinoma lesions with α-fetoprotein (AFP)–producing tumors with those of recipients with tumors that do not produce AFP.
This Viewpoint discusses the current liver allocation policy, which has led to increasing geographic disparity in access to liver transplantation across the United States.
This case series assesses the efficacy of liver transplantation in children with advanced hepatocellular carcinoma or hepatoblastoma.
This case serues of patients undergoing liver transplant reports on damage control as a viable strategy for liver transplant recipients with coagulopathy or hemodynamic instability after allograft reperfusion.
A telehealth intervention is described in patients following liver transplantation.
This retrospective analysis shows that liver transplantation is a valid therapeutic option in selected patients with benign solid liver tumors who are not amenable to resection.
This retrospective analysis demonstrated that more than 2 million life-years were saved by solid-organ transplants during a 25-year study period.
Waits et al investigate the relationship between survival of liver transplant recipients and a new measure of surgical risk assessment they term morphometric age.
Hong et al compare long-term outcomes for children (aged ≤18 years) undergoing orthotopic liver transplantation using grafts from donation after circulatory death and donation after brain death.
Rodriguez-Davalos et al describe the use of segmental allograft in the current era of donor scarcity, minimizing vascular complications using innovative surgical techniques.